View image online ( Medication Vial An 86-year-old female patient with a history of dementia, diabetes and obesity was started on semaglutide by her medical subspecialist to improve glycemic control
Per pound lost, it is not uniquely catabolic
GLP-1 receptor agonists (GLP-1 RAs) are long-acting versions of this signal (liraglutide, semaglutide, dulaglutide, and the dual GIP/GLP-1 agent tirzepatide) developed to treat type 2 diabetes and, more recently, obesity
However, access can be difficult due to limited insurance coverage, high costs, and confusion around eligibility criteria
Understanding GLP-1 Receptor Agonists GLP-1 receptor agonists mimic the effects of the natural GLP-1 hormone, which stimulates insulin secretion, suppresses glucagon, delays gastric emptying and promotes satiety